Literature DB >> 7960627

Single breath-hold pulmonary magnetic resonance angiography. Optimization and comparison of three imaging strategies.

G D Rubin1, R J Herfkens, N J Pelc, T K Foo, S Napel, A Shimakawa, R M Steiner, C J Bergin.   

Abstract

RATIONALE AND
OBJECTIVES: Ultrafast gradient-recalled-echo techniques for obtaining high-quality pulmonary magnetic resonance angiograms within a single breath-hold were optimized.
METHODS: Fourteen subjects were imaged with both the body coil and a phased-array surface coil, using three gradient-recalled-echo pulse sequences: 1) two-dimensional sequential; 2) two-dimensional interleaved; and 3) volumetric acquisitions. Image quality was assessed with varied flip angle, receiver bandwidth, slice thickness/number, and matrix size. Cardiac compensation diminished ghost artifacts in the interleaved sequence. Individual sagittal sections and maximum intensity projections were reviewed.
RESULTS: Pulmonary magnetic resonance angiograms acquired with volumetric and two-dimensional interleaved gradient-recalled-echo pulse sequences benefit greatest from intravenous gadolinium and result in greater pulmonary arterial visualization than traditional time-of-flight techniques. Phased-array coils result in improved vessel detection.
CONCLUSIONS: High-quality breath-held pulmonary magnetic resonance angiography can be obtained with an intravenous contrast-enhanced gradient-recalled-echo acquisition; however, image quality is dependent on the pulse sequence.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7960627     DOI: 10.1097/00004424-199408000-00006

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  2 in total

Review 1.  Ultra-high-speed MR imaging.

Authors:  C P Davis; G C McKinnon; J F Debatin; G K von Schulthess
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

2.  Molecular imaging with endogenous substances.

Authors:  Klaes Golman; Jan H Ardenkjaer-Larsen; J Stefan Petersson; Sven Mansson; Ib Leunbach
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-20       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.